Glioblastoma with brainstem leptomeningeal pseudoprogression following radiation therapy

In brain tumor patients, worsening of imaging findings in the first 6 months after surgical debulking and chemoradiation can occur in the absence of tumor growth, a phenomenon known as pseudoprogression. Awareness of pseudoprogression is important as it can lead to unnecessary additional changes in...

Full description

Bibliographic Details
Main Authors: Nikhar Kinger, MD, Michael J. Hoch, MD, Hui-Kuo G. Shu, MD, Brent D. Weinberg, MD, PhD
Format: Article
Language:English
Published: Elsevier 2019-05-01
Series:Radiology Case Reports
Online Access:http://www.sciencedirect.com/science/article/pii/S1930043318305600
_version_ 1828941382010535936
author Nikhar Kinger, MD
Michael J. Hoch, MD
Hui-Kuo G. Shu, MD
Brent D. Weinberg, MD, PhD
author_facet Nikhar Kinger, MD
Michael J. Hoch, MD
Hui-Kuo G. Shu, MD
Brent D. Weinberg, MD, PhD
author_sort Nikhar Kinger, MD
collection DOAJ
description In brain tumor patients, worsening of imaging findings in the first 6 months after surgical debulking and chemoradiation can occur in the absence of tumor growth, a phenomenon known as pseudoprogression. Awareness of pseudoprogression is important as it can lead to unnecessary additional changes in patient management. In this case, a patient with bilateral frontal glioblastoma presented with new post-treatment brainstem leptomeningeal enhancement which was distant from the original tumor site, concerning for disease progression. However, the patient was asymptomatic and correlation of leptomeningeal enhancement locations with radiation therapy dose maps revealed high doses at the affected site, supporting a diagnosis of treatment effect which was confirmed by resolution on follow-up imaging after treatment with steroids. Parenchymal pseudoprogression in brain tumor patients is well-documented, but worsening leptomeningeal enhancement following therapy may also represent treatment effects. If spatially remote leptomeningeal enhancement occurs, correlation with radiation dose maps may be useful in suggesting a diagnosis of treatment effect over tumor progression. Keywords: Pseudoprogression, Leptomeningeal enhancement, Glioblastoma, Radiation therapy
first_indexed 2024-12-14T03:35:48Z
format Article
id doaj.art-25e650024aa642d8bfcb72d6be7cae50
institution Directory Open Access Journal
issn 1930-0433
language English
last_indexed 2024-12-14T03:35:48Z
publishDate 2019-05-01
publisher Elsevier
record_format Article
series Radiology Case Reports
spelling doaj.art-25e650024aa642d8bfcb72d6be7cae502022-12-21T23:18:37ZengElsevierRadiology Case Reports1930-04332019-05-01145613617Glioblastoma with brainstem leptomeningeal pseudoprogression following radiation therapyNikhar Kinger, MD0Michael J. Hoch, MD1Hui-Kuo G. Shu, MD2Brent D. Weinberg, MD, PhD3Department of Radiology and Imaging Sciences, Emory University, 1364 Clifton Rd NE, BG20, Atlanta, GA 30322 USADepartment of Radiology and Imaging Sciences, Emory University, 1364 Clifton Rd NE, BG20, Atlanta, GA 30322 USADepartment of Radiation Oncology, Emory University, Atlanta, GA, USADepartment of Radiology and Imaging Sciences, Emory University, 1364 Clifton Rd NE, BG20, Atlanta, GA 30322 USA; Corresponding author.In brain tumor patients, worsening of imaging findings in the first 6 months after surgical debulking and chemoradiation can occur in the absence of tumor growth, a phenomenon known as pseudoprogression. Awareness of pseudoprogression is important as it can lead to unnecessary additional changes in patient management. In this case, a patient with bilateral frontal glioblastoma presented with new post-treatment brainstem leptomeningeal enhancement which was distant from the original tumor site, concerning for disease progression. However, the patient was asymptomatic and correlation of leptomeningeal enhancement locations with radiation therapy dose maps revealed high doses at the affected site, supporting a diagnosis of treatment effect which was confirmed by resolution on follow-up imaging after treatment with steroids. Parenchymal pseudoprogression in brain tumor patients is well-documented, but worsening leptomeningeal enhancement following therapy may also represent treatment effects. If spatially remote leptomeningeal enhancement occurs, correlation with radiation dose maps may be useful in suggesting a diagnosis of treatment effect over tumor progression. Keywords: Pseudoprogression, Leptomeningeal enhancement, Glioblastoma, Radiation therapyhttp://www.sciencedirect.com/science/article/pii/S1930043318305600
spellingShingle Nikhar Kinger, MD
Michael J. Hoch, MD
Hui-Kuo G. Shu, MD
Brent D. Weinberg, MD, PhD
Glioblastoma with brainstem leptomeningeal pseudoprogression following radiation therapy
Radiology Case Reports
title Glioblastoma with brainstem leptomeningeal pseudoprogression following radiation therapy
title_full Glioblastoma with brainstem leptomeningeal pseudoprogression following radiation therapy
title_fullStr Glioblastoma with brainstem leptomeningeal pseudoprogression following radiation therapy
title_full_unstemmed Glioblastoma with brainstem leptomeningeal pseudoprogression following radiation therapy
title_short Glioblastoma with brainstem leptomeningeal pseudoprogression following radiation therapy
title_sort glioblastoma with brainstem leptomeningeal pseudoprogression following radiation therapy
url http://www.sciencedirect.com/science/article/pii/S1930043318305600
work_keys_str_mv AT nikharkingermd glioblastomawithbrainstemleptomeningealpseudoprogressionfollowingradiationtherapy
AT michaeljhochmd glioblastomawithbrainstemleptomeningealpseudoprogressionfollowingradiationtherapy
AT huikuogshumd glioblastomawithbrainstemleptomeningealpseudoprogressionfollowingradiationtherapy
AT brentdweinbergmdphd glioblastomawithbrainstemleptomeningealpseudoprogressionfollowingradiationtherapy